Apyx Medical Corp
APYX
Market Cap$86.55M
Close$
$2.40
5.4% upside
Current Fair Value
5.4% upsideUndervalued by 5.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $86.55 Million |
|---|---|
| Enterprise Value | $62.63 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.66 |
| Beta | 1.2 |
| Outstanding Shares | 35,542,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.06 |
|---|---|
| PEG | 8.98 |
| Price to Sales | 2.28 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.11 |
| Enterprise Value to EBIT | -4.13 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.67 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Apyx Medical Corp
CEO: Charles Goodwin